Stay updated on Acalabrutinib vs Ibrutinib in CLL Clinical Trial

Sign up to get notified when there's something new on the Acalabrutinib vs Ibrutinib in CLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Acalabrutinib vs Ibrutinib in CLL Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.3 to v3.5.4, indicating a minor version update.
    Difference
    0.0%
    Check dated 2026-05-15T02:17:38.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    A new page revision tag v3.5.3 was added, replacing the previous v3.5.2. This is a metadata-level change that does not alter visible content or user interactions.
    Difference
    0.0%
    Check dated 2026-04-30T17:26:03.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    - Page revision label updated from v3.5.0 to v3.5.2. No substantive changes to study details or content are evident.
    Difference
    0.0%
    Check dated 2026-04-16T11:12:08.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The study now lists 130 locations and has removed Istanbul, Türkiye. A link to the Genetic and Rare Diseases Information Center is added, and the term B-cell chronic lymphocytic leukemia is included.
    Difference
    0.3%
    Check dated 2026-04-02T05:46:04.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3 as part of the page's revision history.
    Difference
    0.0%
    Check dated 2026-03-18T20:48:50.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3; removed Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T17:48:22.000Z thumbnail image

Stay in the know with updates to Acalabrutinib vs Ibrutinib in CLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Acalabrutinib vs Ibrutinib in CLL Clinical Trial page.